Singapore markets closed
Straits Times Index
3,323.38 +0.18 (+0.01%) S&P 500
5,266.95 -39.09 (-0.74%) Dow
38,441.54 -411.32 (-1.06%) Nasdaq
16,920.58 -99.30 (-0.58%) Bitcoin USD
67,770.12 +80.69 (+0.12%) CMC Crypto 200
1,455.46 -0.41 (-0.03%)
BLUE Aug 2024 0.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:43PM EDT. Market open.
| Previous close | 0.0500 |
| Open | 0.0700 |
| Bid | 0.0000 |
| Ask | 0.1000 |
| Strike | 0.50 |
| Expiry date | 2024-08-16 |
| Day's range | 0.0500 - 0.1000 |
| Contract range | N/A |
| Volume | |
| Open interest | 16 |
Business Wirebluebird bio Appoints O. James Sterling as Chief Financial Officer
SOMERVILLE, Mass., May 29, 2024--bluebird bio, Inc. (Nasdaq: BLUE) today announced that O. James Sterling, has been appointed chief financial officer (CFO), effective June 10, 2024. Mr. Sterling most recently served as chief financial officer of Renalytix plc, a diagnostics company focused on clinical management of kidney disease.
- GuruFocus.com
bluebird bio Inc (BLUE) Q1 2024 Earnings: Surpasses Revenue Expectations with Strategic Focus ...
Detailed Analysis of Financial Performance and Future Outlook
Zacksbluebird (BLUE) Tops on Q1 Sales, Zynteglo Progresses Well
bluebird (BLUE) beats sales estimates in the first quarter on increased Zynteglo product revenues. The company is on track with the ongoing launch of its gene therapies.
© 2024 Yahoo. All rights reserved.